NEW BRIEF: Promoting Transparency and Competition in the Drug Market

DOWNLOAD THE BRIEF

BY WAYNE WINEGARDEN AND CELINE BOOKIN

In addition to the reforms to the health insurance system, which will help address the problems of drug affordability, reforms tailored to the pharmaceutical sector are necessary. These reforms should eliminate drug supply chain inefficiencies and include:

• fostering a patient-controlled generics market,
• creating price transparency through reforms that ensure patients directly benefit from all discounts when purchasing their medicines, 
• fixing the drug formularies’ systemic biases against low-cost medicines, and
• encouraging contracting innovations that could create more innovative ways for pricing medicines.

Read the entire Coverage Denied Series.